by Mandeep Sehmi | Apr 2022 | Press Releases
Isogenica-Phenotypeca Further Collaboration through Medilink Award Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Read the Press Release Isogenica are furthering their collaboration with Phenotypeca, whose platform will deploy...
by Mandeep Sehmi | Mar 2022 | Press Releases
Isogenica-Phenotypeca SMART Grant Collaboration Isogenica-Phenotypeca collaboration spear-headed by SMART Grant award Read the Press Release Isogenica are collaborating with Phenotypeca, a biofoundry business who create and own yeast synthetic biology solutions...
by Isogenica Webmaster | Sep 2021 | Press Releases, Welcome
Isogenica-PipeBio Collaboration Press Release Isogenica announce deployment of the PipeBio Bioinformatic Cloud Read the Press Release Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug...
by Mandeep Sehmi | May 2021 | Press Releases, Welcome
Isogenica announced today that Dr William (Bill) Eldridge has been promoted to Chief Scientific Officer. Since joining Isogenica as Senior Director of Antibody Alliances in January 2020, Dr Eldridge has played a leading role in delivering Isogenica’s multi-target...
by Isogenica Webmaster | Jan 2021 | Press Releases, Welcome
Isogenica multi-year multi-target collaboration with Aro Biotherapeutics extended Isogenica-Aro collaboration goes from strength to strength Read The Press Release Isogenica today announced the collaboration and license agreement signed with Aro Biotherapeutics in...
by Isogenica Webmaster | Jan 2020 | Press Releases, Welcome
Isogenica announces multimillion-pound agreement with recently nasdaq listed BioNTech SE Isogenica multi-target, multi-year collaboration and license agreement with BioNTech SE Isogenica has entered into a multi-target, multi-year partnership with BioNTech. The...
